Inhibition of Streptococcus pneumoniae adherence to human epithelial cells in vitro by the probiotic Lactobacillus rhamnosus GG - PubMed (original) (raw)
Inhibition of Streptococcus pneumoniae adherence to human epithelial cells in vitro by the probiotic Lactobacillus rhamnosus GG
Sook-San Wong et al. BMC Res Notes. 2013.
Abstract
Background: Colonization of the nasopharynx by Streptococcus pneumoniae is considered a prerequisite for pneumococcal infections such as pneumonia and otitis media. Probiotic bacteria can influence disease outcomes through various mechanisms, including inhibition of pathogen colonization. Here, we examine the effect of the probiotic Lactobacillus rhamnosus GG (LGG) on S. pneumoniae colonization of human epithelial cells using an in vitro model. We investigated the effects of LGG administered before, at the same time as, or after the addition of S. pneumoniae on the adherence of four pneumococcal isolates.
Results: LGG significantly inhibited the adherence of all the pneumococcal isolates tested. The magnitude of inhibition varied with LGG dose, time of administration, and the pneumococcal isolate used. Inhibition was most effective when a higher dose of LGG was administered prior to establishment of pneumococcal colonization. Mechanistic studies showed that LGG binds to epithelial cells but does not affect pneumococcal growth or viability. Administration of LGG did not lead to any significant changes in host cytokine responses.
Conclusions: These findings demonstrate that LGG can inhibit pneumococcal colonization of human epithelial cells in vitro and suggest that probiotics could be used clinically to prevent the establishment of pneumococcal carriage.
Figures
Figure 1
Time-course of pneumococcal adherence to epithelial cells. Cells were inoculated with 7.2 x 105 CFU (95%CI 5.8 x 105, 8.7 × 105 CFU) and the number of adherent pneumococci measured over three hours. Mean ± SD for four pneumococcal isolates are depicted (n=2).
Figure 2
Effect of LGG on pneumococcal adherence to epithelial cells. Pneumococcal adherence was determined when incubated with medium alone (Pnc), or with medium containing 100 U/ml heparin (Heparin), or ~5 x 106 CFU LGG (LGG low), or ~5 x 107 CFU LGG (LGG high) added one hour before (A), concurrently (B), or one hour after adding pneumococci (C). One-way ANOVA revealed significant differences in adherence levels (P < 0.05) for all isolates except PMP812 (serotype 5) in the post-addition assay. For each isolate, Bonferroni’s post-test was used to compare heparin, LGG low, and LGG high to Pnc: *, P < 0.001; #, P < 0.05. Data are mean + SD (n≥3).
Figure 3
Effect of LGG on epithelial cytokine production. Concentrations of IL-6 and IL-8 in culture supernatants of untreated epithelial cells (epithelial) or epithelial cells incubated with pneumococci (Pnc), pneumococci with 100 U/ml heparin (Heparin); or~5 × 106 CFU LGG (LGG low), or ~5 × 107 CFU LGG (LGG high) added one hour prior to the addition of pneumococcal isolates PMP843 (serotype 19 F) (A and C) and PMP6 (serotype 5) (B and D) in the adherence assay. Data reported as mean + SD (n=3).
Similar articles
- Investigating the effects of probiotics on pneumococcal colonization using an in vitro adherence assay.
Dunne EM, Toh ZQ, John M, Manning J, Satzke C, Licciardi P. Dunne EM, et al. J Vis Exp. 2014 Apr 28;(86):51069. doi: 10.3791/51069. J Vis Exp. 2014. PMID: 24797941 Free PMC article. - Antifungal defense of probiotic Lactobacillus rhamnosus GG is mediated by blocking adhesion and nutrient depletion.
Mailänder-Sánchez D, Braunsdorf C, Grumaz C, Müller C, Lorenz S, Stevens P, Wagener J, Hebecker B, Hube B, Bracher F, Sohn K, Schaller M. Mailänder-Sánchez D, et al. PLoS One. 2017 Oct 12;12(10):e0184438. doi: 10.1371/journal.pone.0184438. eCollection 2017. PLoS One. 2017. PMID: 29023454 Free PMC article. - Health benefits of Lactobacillus rhamnosus GG and Bifidobacterium animalis subspecies lactis BB-12 in children.
Szajewska H, Hojsak I. Szajewska H, et al. Postgrad Med. 2020 Jun;132(5):441-451. doi: 10.1080/00325481.2020.1731214. Epub 2020 Feb 26. Postgrad Med. 2020. PMID: 32059116 Review. - Thirty Years of Lactobacillus rhamnosus GG: A Review.
Capurso L. Capurso L. J Clin Gastroenterol. 2019 Mar;53 Suppl 1:S1-S41. doi: 10.1097/MCG.0000000000001170. J Clin Gastroenterol. 2019. PMID: 30741841 Review.
Cited by
- Competitive Dominance within Biofilm Consortia Regulates the Relative Distribution of Pneumococcal Nasopharyngeal Density.
Wu X, Jacobs NT, Bozio C, Palm P, Lattar SM, Hanke CR, Watson DM, Sakai F, Levin BR, Klugman KP, Vidal JE. Wu X, et al. Appl Environ Microbiol. 2017 Aug 1;83(16):e00953-17. doi: 10.1128/AEM.00953-17. Print 2017 Aug 15. Appl Environ Microbiol. 2017. PMID: 28576759 Free PMC article. - In vitro anti-tuberculosis effect of probiotic Lacticaseibacillus rhamnosus PMC203 isolated from vaginal microbiota.
Rahim MA, Seo H, Kim S, Tajdozian H, Barman I, Lee Y, Lee S, Song HY. Rahim MA, et al. Sci Rep. 2022 May 18;12(1):8290. doi: 10.1038/s41598-022-12413-z. Sci Rep. 2022. PMID: 35585245 Free PMC article. - Pneumococcal within-host diversity during colonization, transmission and treatment.
Tonkin-Hill G, Ling C, Chaguza C, Salter SJ, Hinfonthong P, Nikolaou E, Tate N, Pastusiak A, Turner C, Chewapreecha C, Frost SDW, Corander J, Croucher NJ, Turner P, Bentley SD. Tonkin-Hill G, et al. Nat Microbiol. 2022 Nov;7(11):1791-1804. doi: 10.1038/s41564-022-01238-1. Epub 2022 Oct 10. Nat Microbiol. 2022. PMID: 36216891 Free PMC article. - Probiotics and carriage of Streptococcus pneumoniae serotypes in Danish children, a double-blind randomized controlled trial.
Fjeldhøj S, Laursen RP, Larnkjær A, Mølgaard C, Fuursted K, Krogfelt KA, Slotved HC. Fjeldhøj S, et al. Sci Rep. 2018 Oct 15;8(1):15258. doi: 10.1038/s41598-018-33583-9. Sci Rep. 2018. PMID: 30323328 Free PMC article. Clinical Trial. - No evidence of harms of probiotic Lactobacillus rhamnosus GG ATCC 53103 in healthy elderly-a phase I open label study to assess safety, tolerability and cytokine responses.
Hibberd PL, Kleimola L, Fiorino AM, Botelho C, Haverkamp M, Andreyeva I, Poutsiaka D, Fraser C, Solano-Aguilar G, Snydman DR. Hibberd PL, et al. PLoS One. 2014 Dec 1;9(12):e113456. doi: 10.1371/journal.pone.0113456. eCollection 2014. PLoS One. 2014. PMID: 25438151 Free PMC article. Clinical Trial.
References
- O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374(9693):893–902. doi: 10.1016/S0140-6736(09)61204-6. - DOI - PubMed
- Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, Muenz LR, O’Brien KL. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010;7(10):e1000348. doi: 10.1371/journal.pmed.1000348. - DOI - PMC - PubMed
- Mulholland K, Satzke C. Serotype replacement after pneumococcal vaccination. Lancet. 2012;379(9824):1387. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources